1. Molnupiravir Is Next
In the next five weeks or so, kids 5 and over will be able to get a vaccine for COVID.
Today we have news that Merck’s antiviral pill, Molnupiravir, is moving forward to seek approval from the FDA.
Initial studies suggest that Molnupiravir—Worst. Branding. Ever.—will reduce hospitalizations and deaths among symptomatic…
Join Bulwark+ to unlock the rest
Become a paying member of The Bulwark to get access to this post and other subscriber-only content. A subscription gets you:
- Unlimited access to articles and newsletters including The Triad by JVL and Receipts by Catherine Rampell.
- Ad-free editions of our shows (with transcripts) and member-only shows like The Secret Podcast.
- Plus community chats and commenting features. Your support helps keep our work sustainable and available to those who cannot afford a membership. Cancel anytime.